Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

627 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phytochromes and cryptochromes regulate the differential growth of Arabidopsis hypocotyls in both a PGP19-dependent and a PGP19-independent manner.
Nagashima A, Suzuki G, Uehara Y, Saji K, Furukawa T, Koshiba T, Sekimoto M, Fujioka S, Kuroha T, Kojima M, Sakakibara H, Fujisawa N, Okada K, Sakai T. Nagashima A, et al. Among authors: sekimoto m. Plant J. 2008 Feb;53(3):516-29. doi: 10.1111/j.1365-313X.2007.03358.x. Epub 2007 Dec 12. Plant J. 2008. PMID: 18086281 Free article.
ASO Visual Abstract: Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19-9 Level for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.
Hashimoto D, Satoi S, Yamaki S, Nakayama S, Shibata N, Matsumura K, Miyazaki H, Matsui Y, Tsybulskyi D, Sang NT, Ikeura T, Kanai M, Sekimoto M. Hashimoto D, et al. Among authors: sekimoto m. Ann Surg Oncol. 2025 Feb;32(2):1341. doi: 10.1245/s10434-024-16502-3. Ann Surg Oncol. 2025. PMID: 39542964 No abstract available.
Spontaneous high clonal expansion of Wilms' tumor gene 1-specific cytotoxic T-lymphocytes in patients with Wilms' tumor gene 1-expressing solid tumor.
Morimoto S, Tanaka Y, Nakata J, Fujiki F, Hasegawa K, Nakajima H, Nishida S, Tsuboi A, Hosen N, Kagawa N, Maruno M, Myoui A, Enomoto T, Izumoto S, Sekimoto M, Hashimoto N, Yoshimine T, Kumanogoh A, Oji Y, Oka Y, Sugiyama H. Morimoto S, et al. Among authors: sekimoto m. Cancer Immunol Immunother. 2024 Nov 7;74(1):15. doi: 10.1007/s00262-024-03862-8. Cancer Immunol Immunother. 2024. PMID: 39509060 Free PMC article.
Influence of major hepatectomy on gemcitabine-based chemotherapy for recurrent biliary tract cancer after surgery: a subgroup analysis of JCOG1113.
Okuno T, Morizane C, Mizusawa J, Yanagimoto H, Kobayashi S, Imaoka H, Terashima T, Kawakami H, Sano Y, Okusaka T, Ikeda M, Ozaka M, Miwa H, Todaka A, Shimizu S, Mizuno N, Sekimoto M, Sano K, Tobimatsu K, Katanuma A, Gotoh K, Yamaguchi H, Ishii H, Furuse J, Ueno M. Okuno T, et al. Among authors: sekimoto m. Int J Clin Oncol. 2025 Jan;30(1):83-91. doi: 10.1007/s10147-024-02642-9. Epub 2024 Oct 23. Int J Clin Oncol. 2025. PMID: 39441453 Clinical Trial.
Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19-9 Level for Resectable/Borderline Resectable Pancreatic Ductal Adenocarcinoma.
Hashimoto D, Satoi S, Yamaki S, Nakayama S, Shibata N, Matsumura K, Miyazaki H, Matsui Y, Tsybulskyi D, Sang NT, Ikeura T, Kanai M, Sekimoto M. Hashimoto D, et al. Among authors: sekimoto m. Ann Surg Oncol. 2025 Jan;32(1):517-528. doi: 10.1245/s10434-024-16361-y. Epub 2024 Oct 21. Ann Surg Oncol. 2025. PMID: 39433718
627 results